Eric RougemondÂ
Chief Executive Officer
administration
Sternco Engineers Inc.
France
Biography
Dr. Eric Rougemond, M.D. has been Chief Executive Officer at PX'Therapeutics SAS since June 2013. Dr. Rougemond serves as Chief Executive Officer of Laboratoire Aguettant. He was formerly the General Manager (France) and Vice President of EUSA Pharma. He served as Medical Director of EUSA Pharma SAS since February 2005. Dr. Rougemond is incharge of medical affairs and marketing activities of Opi Sas. Dr. Rougemond is Specialized in medical biology, he made his cursus at the Hospices Civils de Lyon. He then moved at Merck Lipha Santé, subsidiary of Merck KgAa, as medical adviser. He served as Medical Director at Merck KGaA and OPi. He was appointed in 2001 medical director in charge of medical affairs and regulatory affairs. He has extensive experience in the life sciences industry .He is a Medical Doctor by training specializing in Clinical Biology. He studied at Université Claude Bernard - Université Lyon I.
Research Interest
business
